The OpenAI Foundation has announced a new initiative, Public Data for Health, aimed at generating and securing high-quality scientific datasets to improve the performance of artificial intelligence in medical research. The foundation, which serves as the nonprofit parent of OpenAI, is prioritizing data acquisition to overcome what experts describe as a significant bottleneck in applying AI to biological challenges.
A central component of this initiative is a $500,000 grant awarded to the advocacy group 1Day Sooner. The funding supports a proposal by policy analyst Ruxandra Teslo to acquire regulatory filings, safety data, and manufacturing strategies from bankrupt biotechnology companies. These documents, often referred to as “biotech’s lost archive,” are typically treated as trade secrets but could prove instrumental in training AI models to navigate the complex drug approval process.
Josh Morrison, president and cofounder of 1Day Sooner, stated that the grant will help the organization demonstrate the feasibility of obtaining these data troves. The group has already secured three datasets, including two donated by Lumen Bioscience, though other attempts to acquire similar files through bankruptcy proceedings have faced challenges.
Beyond the biotech archive project, the foundation has committed $40 million to support cancer vaccine data collection at the University of North Carolina, Chapel Hill, and to assist OpenAdmet, an organization that hosts research competitions focused on predicting drug effects. Jacob Trefethen, an executive at the foundation, noted that the organization aims to distribute $1 billion in grants by the end of the year to support research that ensures AI benefits humanity.
The foundation’s grantmaking efforts arrive as the broader AI industry faces intense scrutiny regarding safety and the potential for rapid model development to outpace risk mitigation. While the foundation operates independently of OpenAI’s for-profit arm, it holds a significant equity stake in the company, positioning it to become one of the world's most well-funded charitable organizations.
Source: MIT Technology Review
No comments yet. Be the first to share your thoughts.